Cesarean Section Complications: Clinical Trials

4 trials for Cesarean Section Complications, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Completed 4
Phase 11Completed 1
Phase 31Completed 1

Follow Cesarean Section Complications: new trials by email Literature Review of Cesarean Section Complications trials Research Report on Cesarean Section Complications

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Vasopressin vs. Uterine Artery Clamping for Laparoscopic Cesarean Scar Niche Repair
Vasopressin Group, Bulldog Clamping Group, Standard of Care - Cesarean Section Complications
Phase 2CompletedZagazig University302024-03-202026-03-03
Effect of Autologous Platelet-rich Plasma in Uterine Wound Healing
autologus platelet rich plasma, placebo - Cesarean Section Complications
Phase 2CompletedAin Shams University1342020-02-012021-07-21
Calcium Chloride for Prevention of Uterine Atony During Cesarean
Calcium Chloride, Placebo - Uterine Atony, Uterine Atony With Hemorrhage
Phase 1 / Phase 2CompletedStanford University402019-03-152022-04-28
The Phenylephrine vs. Norepinephrine Infusion Undergoing Cesarean Section
Norepinephrine, Phenylephrine, Ringer's Solution - Cesarean Section Complications
Phase 2 / Phase 3CompletedChina International Neuroscience Institution2382019-02-202020-02-10

Narrower conditions

Uterine Inertia (1)

Broader conditions

Dystocia (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Obstetric Labor Complications (1)  ·  Pregnancy Complications (1)  ·  Urogenital Diseases (1)

Interventions

Calcium (1)  ·  Calcium Chloride (1)  ·  Metals, Alkali (1)  ·  Metals, Alkaline Earth (1)  ·  Norepinephrine (1)  ·  Phenylephrine (1)  ·  Ringer's Solution (1)  ·  Sodium Chloride (1)  ·  Standard of Care (1)

Sponsors

Ain Shams University (1)  ·  China International Neuroscience Institution (1)  ·  Stanford University (1)  ·  Zagazig University (1)

Countries

China (1)  ·  Egypt (1)  ·  Saudi Arabia (1)  ·  United States (1)

Top investigators

Brendan Carvalho, MBBCh FRCA (1)  ·  Tianlong Wang, MD,PHD (1)

Results publications

PMID 32894044, PMID 35447502